2Payne DA,Jones CI,hayes PD,et al.Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid andarterectomy[J].Circulation,2004,109(12):1476-1481.
3Orford JL,FasseasP,Melby S,et al.Safety and efficacy of aspirin,clopidogrel,and warfarin after coronary stent placement in patients with an indication for anticoagulation[J].Am Heart J,2004,147(3):463-467.
4Howk,Hankey GJ,Eikelboom JW.Prevention of coronary heart disease with aspirin and clopidogrel:efficacy,safety,costa and cost-effectiveness[J].Exepert Opin Pharmacother,2004,5(3):493-503.
5Bhatt DL,Topol EJ.Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention:rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,Management,and Avoidance (CHARISMA) trial[J].Am Heart J,2004,148(2):263-268.
6Matetzky S,Shenkman B,Guetta V,et al.Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction[J].Circulation,2004,109(25):3171-3175.
7Kandzari DE,Berger PB,Kastrati A,et al.Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization[J].J Am Coll Cardiol,2004,44(11):2133-2136.
8CassarK,Ford I,Greaves M,et al.Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty[J].Br J Surg,2005,92(2):159-165.
9Cowper PA,Udayakumar K,Sketch MH,et al.Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention[J].J Am Coll Cardiol,2005,45(3):369-376.
10Stern R,Wolfe F.Infliximab dose and clinical status:results of 2 studies in 1642 patients with rheumatoid arthritis[J].J Rheumatol,2004,31(8):1538-1545.
二级参考文献11
1[1]Easthope SE,Javis B.Clopidogrel:potential in the prevention of cardiovascular events in patients with acute coronary syndromes[J].Am J Cardiovasc Drugs,2001,1(6):467-476.
2[2]Gruber A,Hanson SR.Potential new targets for antithrombotic therapy[J].Curr Pharm Des,2003,9(28):2367-2374.
4[4]Ho WK,Hankey GJ,Eikelboom JW.Prevention of coronary heart disease with aspirin and clopidogrel:efficacy,safety,costs and cost-effectiveness[J].Expert Opin Pharmacother,2004,5(3):493-503.
5[5]Weltermann A,Fritsch P,Kyrle PA,et al.Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting[J].Thromb Res,2003,112(1-2):19-24.
6[6]Payne DA,Jones CI,Hayes PD,et al.Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy[J].Circulation,2004,109(12):1476-1481.
7[7]Orford JL,Fasseas P,Melby S,et al.Safety and efficacy of aspirin,clopidogrel,and warfarin after coronary stent placement in patients with an indication for anticoagulation[J].Am Heart J,2004,147(3):463-467.
8[8]Mobley JE,Bresee SJ,Wortham DC,et al.Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization[J].Am J Cardiol,2004,93(4):456-458.
9[9]Casella G,Ottani F,Pavesi PC,et al.Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation:an updated meta-analysis[J].Ital Heart J,2003,4(10):677-684.
10[10]Shennib H,Endo M,Benhameid O.A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting[J].Heart Surg Forum,2003,6(5):288-291.
2Bowry A, Brookhart M, Choudhry NK. Meta analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events[J]. Am J Cardial, 2008, 101 (7): 960-966.
3Sabatine MS, Cannon CP, Gibson CM, et al. Addition of elopidogsel to aspirin and fibrinolytie therapy for myocardial infaretion with ST-segment elevation [J]. N Engl J Med, 2005, 352 (12) : 1179-1189.
6Mehta SR, Yusttf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing peleotaneous coronary intervention: The PC1-CURE study[J]. Lancet, 2001, 358 (9281): 527-533.
